EP3721228A4 - Assay und point-of-care-vorrichtung mit verwendung von speichel zur diagnose und behandlung von neurologischen, die gehirngesundheit beeinträchtigenden zuständen - Google Patents

Assay und point-of-care-vorrichtung mit verwendung von speichel zur diagnose und behandlung von neurologischen, die gehirngesundheit beeinträchtigenden zuständen Download PDF

Info

Publication number
EP3721228A4
EP3721228A4 EP18885650.4A EP18885650A EP3721228A4 EP 3721228 A4 EP3721228 A4 EP 3721228A4 EP 18885650 A EP18885650 A EP 18885650A EP 3721228 A4 EP3721228 A4 EP 3721228A4
Authority
EP
European Patent Office
Prior art keywords
diagnosis
assay
treatment
point
care device
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP18885650.4A
Other languages
English (en)
French (fr)
Other versions
EP3721228A1 (de
Inventor
Damir Janigro
Aaron Dudas
Edward J. Rapp
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Flotbi Inc
Original Assignee
Flotbi Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US15/833,160 external-priority patent/US11717195B2/en
Application filed by Flotbi Inc filed Critical Flotbi Inc
Publication of EP3721228A1 publication Critical patent/EP3721228A1/de
Publication of EP3721228A4 publication Critical patent/EP3721228A4/de
Pending legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G01N33/54386—Analytical elements
    • G01N33/54387—Immunochromatographic test strips
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G01N33/54386—Analytical elements
    • G01N33/54387—Immunochromatographic test strips
    • G01N33/54388—Immunochromatographic test strips based on lateral flow
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Medical Informatics (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Data Mining & Analysis (AREA)
  • Databases & Information Systems (AREA)
  • Neurology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Primary Health Care (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
EP18885650.4A 2017-12-06 2018-11-29 Assay und point-of-care-vorrichtung mit verwendung von speichel zur diagnose und behandlung von neurologischen, die gehirngesundheit beeinträchtigenden zuständen Pending EP3721228A4 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15/833,160 US11717195B2 (en) 2015-10-12 2017-12-06 Assay and point of care device utilizing saliva for diagnosis and treatment of neurological conditions affecting brain health
PCT/US2018/062937 WO2019112863A1 (en) 2017-12-06 2018-11-29 Assay and point of care device utilizing saliva for diagnosis and treatment of neurological conditions affected brain health

Publications (2)

Publication Number Publication Date
EP3721228A1 EP3721228A1 (de) 2020-10-14
EP3721228A4 true EP3721228A4 (de) 2021-12-15

Family

ID=66750327

Family Applications (1)

Application Number Title Priority Date Filing Date
EP18885650.4A Pending EP3721228A4 (de) 2017-12-06 2018-11-29 Assay und point-of-care-vorrichtung mit verwendung von speichel zur diagnose und behandlung von neurologischen, die gehirngesundheit beeinträchtigenden zuständen

Country Status (2)

Country Link
EP (1) EP3721228A4 (de)
WO (1) WO2019112863A1 (de)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014075939A1 (en) * 2012-11-16 2014-05-22 Siemens Aktiengesellschaft Novel mirnas as diagnostic markers
US20140242612A1 (en) * 2011-07-14 2014-08-28 Shuqi Wang System and method for integration of mobile device imaging with microchip elisa
US20150268252A1 (en) * 2009-06-19 2015-09-24 Banyan Biomarkers, Inc. Biomarker assay of neurological condition
US20160203280A1 (en) * 2007-04-26 2016-07-14 Soar Biodynamics, Ltd. Methods and systems of delivering a probability of a medical condition

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009075894A1 (en) * 2007-12-13 2009-06-18 Beckman Coulter, Inc Device and methods for detecting a target cell
EP2628013B1 (de) * 2010-10-14 2019-06-12 The Johns Hopkins University Biomarker für gehirnverletzungen
CN104838264A (zh) * 2012-09-11 2015-08-12 康奈尔大学 用于生物分子反应点收集测量的设备和方法
FI20155280A (fi) * 2015-04-15 2016-10-16 Medicortex Finland Oy Aivovamman prognostisia ja diagnostisia glykaanipohjaisia biomarkkereita
BR112019006710A2 (pt) * 2016-10-03 2019-06-25 Abbott Lab métodos aprimorados para avaliação do estado da uch-l1 em amostras de pacientes

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160203280A1 (en) * 2007-04-26 2016-07-14 Soar Biodynamics, Ltd. Methods and systems of delivering a probability of a medical condition
US20150268252A1 (en) * 2009-06-19 2015-09-24 Banyan Biomarkers, Inc. Biomarker assay of neurological condition
US20140242612A1 (en) * 2011-07-14 2014-08-28 Shuqi Wang System and method for integration of mobile device imaging with microchip elisa
WO2014075939A1 (en) * 2012-11-16 2014-05-22 Siemens Aktiengesellschaft Novel mirnas as diagnostic markers

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2019112863A1 *

Also Published As

Publication number Publication date
EP3721228A1 (de) 2020-10-14
WO2019112863A1 (en) 2019-06-13

Similar Documents

Publication Publication Date Title
EP3695416A4 (de) Tiefenlernbasierte diagnose und überweisung von augenerkrankungen und -störungen
EP3454745A4 (de) Diagnoseanpassung für gesundheit und krankheit
PL3694409T3 (pl) System do charakterystyki, diagnostyki i leczenia schorzenia u pacjenta oraz przewodnictwa mikrotubul
EP3844777A4 (de) Medizinprodukt und verfahren zur diagnose und behandlung von erkrankungen
EP3697925A4 (de) Identifizierung und verwendung biologischer parameter für diagnose und therapieüberwachung
HK1246712A1 (zh) 神經刺激治療疾病及病症
EP2967484A4 (de) System und signaturen für multimodale physiologische stimulation und bewertung der gehirngesundheit
ZA202006386B (en) Central nerve magnetic stimulation device and healthcare or medical instrument having same
EP3583113A4 (de) Verwendung von tgf-alpha zur behandlung von krankheiten und störungen
SG11202004971YA (en) Compositions and methods of treatment for neurological disorders comprising motor neuron diseases
EP3471562A4 (de) Synthetische zusammensetzungen mit muttermilcholigosacchariden zur vorbeugung und behandlung von erkrankungen
EP3648769A4 (de) Aus menschlicher darmflora abgeleitete n-acylamide zur behandlung von krankheiten beim menschen
IL270900A (en) Treatment of skin disorders
EP3852774A4 (de) Verfahren zur diagnose und behandlung von typ-1-diabetes
EP3644966A4 (de) Behandlung und diagnose von störungen der augenoberfläche
EP3413898A4 (de) Verwendung von trehalose zur behandlung von neurologischen erkrankungen
EP3943058A4 (de) Vorrichtung für gesundheitspflege
IL269400A (en) Medicines and preparations for the treatment of eye disorders
EP3746796A4 (de) Diagnose und behandlung von autismus-spektrum-störungen auf basis von aminenhaltigen metabotypen
PL3852663T3 (pl) Urządzenie do leczenia tkanki ciała
EP3721228A4 (de) Assay und point-of-care-vorrichtung mit verwendung von speichel zur diagnose und behandlung von neurologischen, die gehirngesundheit beeinträchtigenden zuständen
EP3737381A4 (de) Medizinische vorrichtung und pharmazeutische zusammensetzung zur behandlung einer augenerkrankung oder eines augenleidens
EP3411479A4 (de) Behandlung und diagnose von entzündungserkrankungen
EP3273982A4 (de) Verfahren zur diagnose oder behandlung neurologischen störungen mit p75ecd und/oder p75
IL263018A (en) A device for monitoring a patient's vital signs

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20200625

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20211116

RIC1 Information provided on ipc code assigned before grant

Ipc: G01N 33/68 20060101ALI20211111BHEP

Ipc: G01N 33/543 20060101ALI20211111BHEP

Ipc: G16H 50/20 20180101ALI20211111BHEP

Ipc: G01N 33/53 20060101AFI20211111BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20240508